Pradaxa 50 mg/1 (Dabigatran Etexilate PELLET) 50 mg/1

Pradaxa 50 mg/1 is a medication containing dabigatran etexilate, used for blood thinning and anticoagulation. This oral pellet form is designed for convenient administration, helping manage conditions related to blood clotting.

Strength

50 mg/1

Pack Size

1 BAG in 1 CARTON (0597-0440-53) / 60 PELLET in 1 BAG

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pradaxa 50 mg/1 is primarily used for anticoagulation, which helps prevent blood clots. It is often prescribed for conditions like atrial fibrillation or after certain surgeries to reduce the risk of stroke and blood clots. People may ask, 'What is Pradaxa used for?' and the answer involves its role in managing blood-related issues.

Side Effects

Common effects of Pradaxa 50 mg/1 may include bleeding more easily, bruising, or experiencing nosebleeds. Some users might also notice digestive issues or dizziness. These effects can vary from person to person, and it's important to monitor any unusual symptoms.

Precautions & Warnings

Pradaxa 50 mg/1 should be handled with care, especially regarding dosage and administration. It's crucial to follow the guidance of a healthcare provider to avoid complications. Store the medication properly and keep it out of reach of children to ensure safety.

Avoid Interactions

Pradaxa 50 mg/1 can interact with various substances, including other medications, supplements, and certain foods. Alcohol and other blood-thinning agents may increase the risk of bleeding. Always inform your healthcare provider about all the substances you are taking to avoid potential interactions.

Frequently Asked Questions

Pradaxa is used for anticoagulation to prevent blood clots, often in conditions like atrial fibrillation or post-surgery.

Pradaxa pellets are designed for oral use and should be taken as directed by a healthcare provider.

Common side effects may include increased bleeding, bruising, and digestive issues.

Yes, Pradaxa can interact with other medications, supplements, and certain foods, so it's important to discuss all substances with a healthcare provider.

Pradaxa should be stored according to the instructions provided, typically in a cool, dry place out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.